133 related articles for article (PubMed ID: 38217387)
1. The integrated stress response-related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability.
Vlasveld M; Callegaro G; Fisher C; Eakins J; Walker P; Lok S; van Oost S; de Jong B; Pellegrino-Coppola D; Burger G; Wink S; van de Water B
Liver Int; 2024 Mar; 44(3):760-775. PubMed ID: 38217387
[TBL] [Abstract][Full Text] [Related]
2. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
[TBL] [Abstract][Full Text] [Related]
3. Integration of temporal single cell cellular stress response activity with logic-ODE modeling reveals activation of ATF4-CHOP axis as a critical predictor of drug-induced liver injury.
Wijaya LS; Trairatphisan P; Gabor A; Niemeijer M; Keet J; Alcalà Morera A; Snijders KE; Wink S; Yang H; Schildknecht S; Stevens JL; Bouwman P; Kamp H; Hengstler J; Beltman J; Leist M; Le Dévédec S; Saez-Rodriguez J; van de Water B
Biochem Pharmacol; 2021 Aug; 190():114591. PubMed ID: 33957093
[TBL] [Abstract][Full Text] [Related]
4. High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities.
Wink S; Hiemstra S; Herpers B; van de Water B
Arch Toxicol; 2017 Mar; 91(3):1367-1383. PubMed ID: 27358234
[TBL] [Abstract][Full Text] [Related]
5. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury.
Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B
Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity.
Herpers B; Wink S; Fredriksson L; Di Z; Hendriks G; Vrieling H; de Bont H; van de Water B
Arch Toxicol; 2016 May; 90(5):1163-79. PubMed ID: 26026609
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
[TBL] [Abstract][Full Text] [Related]
8. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
[TBL] [Abstract][Full Text] [Related]
9. The Identification of Pivotal Transcriptional Factors Mediating Cell Responses to Drugs With Drug-Induced Liver Injury Liabilities.
Shah F; Medvedev A; Wassermann AM; Brodney M; Zhang L; Makarov S; Stanton RV
Toxicol Sci; 2018 Mar; 162(1):177-188. PubMed ID: 29106686
[TBL] [Abstract][Full Text] [Related]
10. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
[TBL] [Abstract][Full Text] [Related]
12. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
13. Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice.
Mosedale M; Cai Y; Eaddy JS; Kirby PJ; Wolenski FS; Dragan Y; Valdar W
Toxicology; 2021 Sep; 461():152902. PubMed ID: 34418498
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
[TBL] [Abstract][Full Text] [Related]
16. A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury.
Wijaya LS; Gabor A; Pot IE; van de Have L; Saez-Rodriguez J; Stevens JL; Le Dévédec SE; Callegaro G; van de Water B
Toxicol Sci; 2024 Feb; 198(1):14-30. PubMed ID: 38015832
[TBL] [Abstract][Full Text] [Related]
17. CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.
Uzi D; Barda L; Scaiewicz V; Mills M; Mueller T; Gonzalez-Rodriguez A; Valverde AM; Iwawaki T; Nahmias Y; Xavier R; Chung RT; Tirosh B; Shibolet O
J Hepatol; 2013 Sep; 59(3):495-503. PubMed ID: 23665281
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury.
Copple IM; den Hollander W; Callegaro G; Mutter FE; Maggs JL; Schofield AL; Rainbow L; Fang Y; Sutherland JJ; Ellis EC; Ingelman-Sundberg M; Fenwick SW; Goldring CE; van de Water B; Stevens JL; Park BK
Arch Toxicol; 2019 Feb; 93(2):385-399. PubMed ID: 30426165
[TBL] [Abstract][Full Text] [Related]
19. Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the
Xu Q; Liu L; Vu H; Kuhls M; Aslamkhan AG; Liaw A; Yu Y; Kaczor A; Ruth M; Wei C; Imredy J; Lebron J; Pearson K; Gonzalez R; Mitra K; Sistare FD
Chem Res Toxicol; 2019 Aug; 32(8):1528-1544. PubMed ID: 31271030
[TBL] [Abstract][Full Text] [Related]
20. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
